BACKGROUND: "Clinical inertia" has been defined as inaction by physicians caring for patients with uncontrolled risk factors such as blood pressure. Some have proposed that it accounts for up to 80% of cardiovascular events, potentially an important quality problem. However, reasons for so-called clinical inertia are poorly understood. OBJECTIVE: To derive an empiric conceptual model of clinical inertia as a subset of all clinical inactions from the physician perspective. METHODS: We used Nominal Group panels of practicing physicians to identify reasons why they do not intensify medications when seeing an established patient with uncontrolled blood pressure. MEASUREMENTS AND MAIN RESULTS: We stopped at 2 groups (N = 6 and 7, respectively) because of the high degree of agreement on reasons for not intensifying, indicating saturation. A third group of clinicians (N = 9) independently sorted the reasons generated by the Nominal Groups. Using multidimensional scaling and hierarchical cluster analysis, we translated the sorting results into a cognitive map that represents an empirically derived model of clinical inaction from the physician's perspective. The model shows that much inaction may in fact be clinically appropriate care. CONCLUSIONS/RECOMMENDATIONS: Many reasons offered by physicians for not intensifying medications suggest that low rates of intensification do not necessarily reflect poor quality of care. The empirically derived model of clinical inaction can be used as a guide to construct performance measures for monitoring clinical inertia that better focus on true quality problems.
BACKGROUND: "Clinical inertia" has been defined as inaction by physicians caring for patients with uncontrolled risk factors such as blood pressure. Some have proposed that it accounts for up to 80% of cardiovascular events, potentially an important quality problem. However, reasons for so-called clinical inertia are poorly understood. OBJECTIVE: To derive an empiric conceptual model of clinical inertia as a subset of all clinical inactions from the physician perspective. METHODS: We used Nominal Group panels of practicing physicians to identify reasons why they do not intensify medications when seeing an established patient with uncontrolled blood pressure. MEASUREMENTS AND MAIN RESULTS: We stopped at 2 groups (N = 6 and 7, respectively) because of the high degree of agreement on reasons for not intensifying, indicating saturation. A third group of clinicians (N = 9) independently sorted the reasons generated by the Nominal Groups. Using multidimensional scaling and hierarchical cluster analysis, we translated the sorting results into a cognitive map that represents an empirically derived model of clinical inaction from the physician's perspective. The model shows that much inaction may in fact be clinically appropriate care. CONCLUSIONS/RECOMMENDATIONS: Many reasons offered by physicians for not intensifying medications suggest that low rates of intensification do not necessarily reflect poor quality of care. The empirically derived model of clinical inaction can be used as a guide to construct performance measures for monitoring clinical inertia that better focus on true quality problems.
Authors: Deborah A Levine; Kenneth G Saag; Linda L Casebeer; Cathleen Colon-Emeric; Kenneth W Lyles; Richard M Shewchuk Journal: J Am Med Dir Assoc Date: 2006-07-17 Impact factor: 4.669
Authors: D R Berlowitz; A S Ash; E C Hickey; R H Friedman; M Glickman; B Kader; M A Moskowitz Journal: N Engl J Med Date: 1998-12-31 Impact factor: 91.245
Authors: Nicolas Rodondi; Tiffany Peng; Andrew J Karter; Douglas C Bauer; Eric Vittinghoff; Simon Tang; Daniel Pettitt; Eve A Kerr; Joe V Selby Journal: Ann Intern Med Date: 2006-04-04 Impact factor: 25.391
Authors: Eve A Kerr; Dylan M Smith; Mary M Hogan; Timothy P Hofer; Sarah L Krein; Martin Bermann; Rodney A Hayward Journal: Med Care Date: 2003-10 Impact factor: 2.983
Authors: Carlos A Estrada; Monika M Safford; Amanda H Salanitro; Thomas K Houston; William Curry; Jessica H Williams; Fernando Ovalle; Yongin Kim; Pamela Foster; Jeroan J Allison Journal: Int J Qual Health Care Date: 2011-08-10 Impact factor: 2.038
Authors: Rikki M Tanner; Monika M Safford; Keri L Monda; Benjamin Taylor; Ronan O'Beirne; Melanie Morris; Lisandro D Colantonio; Ricardo Dent; Paul Muntner; Robert S Rosenson Journal: Cardiovasc Drugs Ther Date: 2017-06 Impact factor: 3.727
Authors: Amy G Huebschmann; Trina Mizrahi; Alyssa Soenksen; Brenda L Beaty; Thomas D Denberg Journal: J Clin Hypertens (Greenwich) Date: 2012-03-16 Impact factor: 3.738
Authors: Alexander Turchin; Holly I Wheeler; Matthew Labreche; Julia T Chu; Merri L Pendergrass; Jonathan S Einbinder; Jonathan Seth Einbinder Journal: AMIA Annu Symp Proc Date: 2008-11-06
Authors: Betty M Kennedy; Frederick Cerise; Ronald Horswell; Willene P Griffin; Kathleen H Willis; Sarah Moody-Thomas; Jay A Besse; Peter T Katzmarzyk Journal: Clin Transl Sci Date: 2014-07-25 Impact factor: 4.689
Authors: Ian M Kronish; Shia Kent; Nathalie Moise; Daichi Shimbo; Monika M Safford; Robert E Kynerd; Ronan O'Beirne; Alexandra Sullivan; Paul Muntner Journal: J Am Soc Hypertens Date: 2017-07-06
Authors: Amanda H Salanitro; Ellen Funkhouser; Bonita S Agee; Jeroan J Allison; Jewell H Halanych; Thomas K Houston; Mark S Litaker; Deborah A Levine; Monika M Safford Journal: Implement Sci Date: 2010-07-19 Impact factor: 7.327
Authors: Ken Lee Chin; Marina Skiba; Andrew Tonkin; Christopher M Reid; Danny Liew; Henry Krum; Ingrid Hopper Journal: Heart Fail Rev Date: 2016-11 Impact factor: 4.214